Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010
Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010
Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010
Submitted by
admin
on January 14, 2010 - 9:00am
Source:
Bloomberg
News Tags:
Amgen
denosumab
Headline:
Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010
Do Not Allow Advertisers to Use My Personal information
